Results 41 to 50 of about 27,602 (209)

Comparison of pain after prophylactic anticoagulant injections to prevent venous thromboembolism

open access: yesSurgery Open Science
Subcutaneous injection of unfractionated heparin (UH) or low molecular weight heparin (LMWH) is frequently utilized for venous thromboembolism chemoprophylaxis.
Margaret Shyu   +6 more
doaj   +1 more source

Application of thromboelastography in comparing coagulation difference of rivaroxaban and enoxaparin for thromboprophylaxis after total hip arthroplasty

open access: yesJournal of Orthopaedic Surgery, 2021
Purpose: The purpose of this study was to compare the coagulation difference in patients with either rivaroxaban or enoxaparin as thromboprophylaxis after total hip arthroplasty (THA) regarding thromboelastography (TEG) and routine coagulation tests ...
Chao-wen Bai   +7 more
doaj   +1 more source

Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome

open access: yes, 2007
Caroline Schmidt-Lucke, Heinz-Peter SchultheissCharité Medical University Berlin, Campus Benjamin Franklin, Dept. of Cardiology and Pulmology, GermanyAbstract: Non-ST elevation acute coronary syndrome (NSTE-ACS) refers to a cardiovascular disorder
Caroline Schmidt-Lucke   +1 more
core   +1 more source

Intra-Abdominal Hematoma Following Enoxaparin Injection

open access: yes, 2016
An elderly patient, who was being treated for therapeutic enoxaparin for a couple of days due to suspected deep vein thrombosis, was admitted to hospital following a collapse and severe abdominal pain.
Kin Tong Chung
core   +1 more source

Does the use of postoperative low-molecular-weight heparin in patients with lung cancer increase tube drainage?

open access: yesAsian Journal of Surgery, 2020
Summary: Background: The objectives of this study are to assess the chest drainage volumes of patients undergoing anatomic resection of non-small cell lung carcinoma and to determine the safety and effectiveness of administering enoxaparin for ...
Hıdır Esme   +2 more
doaj   +1 more source

Bioinspired Passive Flow Routing to Mitigate Thrombosis in Prosthetic Heart Valves and Cardiovascular Devices

open access: yesAdvanced Science, EarlyView.
Bioinspired passive flow routing mitigates thrombosis in cardiovascular devices by redirecting a small fraction of forward flow into stagnation‐prone regions. Inspired by avian alula and aircraft slat mechanisms, strategically placed routing channels restore washout around mechanical heart valves, reducing low‐shear exposure by four orders of magnitude
Yevgeniy Kreinin   +8 more
wiley   +1 more source

Enoxaparin vs Fondaparinux Dalam Penurunan CK-MB

open access: yes, 2020
Ischemic Heart Disease (Non ST Elevated Myocardial Infarction-NSTEMI) is the leading cause of death in Indonesia after Stroke. Enoxaparin and Fondaparinux are the drugs of choice for this condition.
sukmawan, yedy purwandi   +2 more
core   +1 more source

Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention

open access: yesPlatelets, 2021
A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y12 inhibitors in opiate-treated ST-elevation ...
Wael Sumaya   +10 more
doaj   +1 more source

Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Cancer care is often complicated by coagulopathy leading to thrombosis and bleeding. While venous thromboembolism (VTE) has been extensively studied, bleeding remains an underestimated threat. To address this knowledge gap, we leveraged the Epic Cosmos database to determine the impact of cancer‐associated clinically relevant bleeding (CRB) in ...
Ming Y. Lim   +11 more
wiley   +1 more source

Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction [PDF]

open access: yes, 2002
Background — ENTIRE-TIMI 23 evaluated enoxaparin with full-dose tenecteplase (TNK) and half-dose TNK plus abciximab.
Hubert F. Baars   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy